Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


KemPharm, Inc. 

7 Hawkeye Drive
Suite 103
North Liberty  Iowa  52317  U.S.A.
Phone: 319-665-2575 Fax: 319-665-2577


 Company News
KemPharm Announces Pricing Of IPO 4/16/2015 7:41:17 AM
KemPharm Sets Terms for $52 Million IPO 4/9/2015 6:16:37 AM
KemPharm, Inc. Appoints David S. Tierney, MD To Board Of Directors 3/10/2015 10:11:48 AM
KemPharm, Inc. Appoints Tracy M. Woody As Chief Commercial Officer 3/4/2015 10:19:01 AM
KemPharm, Inc. Completes Pre-IND Meeting With FDA For NME Prodrug Of Hydromorphone, KP511 12/9/2014 8:33:49 AM
KemPharm, Inc. Receives Notice Of Allowance For NME Prodrug Of Methylphenidate, KP415 12/5/2014 12:20:16 PM
KemPharm, Inc. Receives Patent From The USPTO For Novel Prodrug Of Hydromorphone, KP511 9/30/2014 8:54:38 AM
KemPharm, Inc. Receives Health Canada Approval To Begin KP201 Clinical Trials In Canada 9/23/2014 9:32:31 AM
KemPharm, Inc. Advances KP201 Clinical Program With Initiation Of Human Abuse Liability And Human Gastrointestinal Motility Trials 9/8/2014 8:59:07 AM
KemPharm, Inc. To Present At The Canaccord Genuity 34th Annual Growth Conference 8/6/2014 10:08:11 AM